Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chalazion × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 447 Rectal Neoplasms 248 Colonic Neoplasms 202 Pancreatic Neoplasms 170 Stomach Neoplasms 167 Esophageal Neoplasms 124 Neoplasm Metastasis 106 Breast Neoplasms 105 Head and Neck Neoplasms 84 Squamous Cell Carcinoma of Head and Neck 81 Neoplasms 80 Adenocarcinoma Of Esophagus 61 Esophageal Squamous Cell Carcinoma 54 Carcinoma, Hepatocellular 52 Adenocarcinoma 37 Nasopharyngeal Carcinoma 34 Cholangiocarcinoma 30 Keratosis, Actinic 23 Biliary Tract Neoplasms 23 Anus Neoplasms 23 Gastrointestinal Neoplasms 22 Carcinoma, Squamous Cell 22 Carcinoma, Non-Small-Cell Lung 22 Liver Neoplasms 21 Gallbladder Neoplasms 21 Bile Duct Neoplasms 19 Urinary Bladder Neoplasms 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Nasopharyngeal Neoplasms 15 Carcinoma 13

Interventions

Conservative Treatment 3 Probiotics 2 Curettage 2 tyramine-deoxysorbitol 1 Triamcinolone Acetonide 1 Triamcinolone 1 Tetracycline 1 Loteprednol Etabonate 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡